David focuses his practice on patent prosecution, opinion work, due diligence, and general intellectual property counseling in the areas of biochemistry, molecular biology, cancer biology, immunology, microbiology, genetics, and genomics. By identifying each client’s technology strengths and business goals, David is able to provide a range of high quality, creative legal solutions.

David has particular expertise in prosecuting patents domestically and worldwide in the field of biotechnology and pharmaceuticals, including biologics, stem cell technology, gene therapy, crystallography, and single-molecule techniques. The technical expertise he acquired from his doctoral and post-doctoral training at prestigious universities and research institutions enables him to adapt rapidly to various cutting-edge technologies.

Some representative matters include:

  • Drafted and successfully prosecuted numerous biotech/pharmaceutical patent applications filed with the U.S. Patent and Trademark Office and in foreign jurisdictions.
  • Prepared extensive freedom to operate opinion and product/technology clearances for various clients.
  • Strategically managed multiple patent portfolios for a range of clients including multinational pharmaceutical companies and startups.

David’s Ph.D. thesis focused on the molecular mechanisms of mRNA export, RNA interference and microRNA biogenesis. He also investigated the molecular biology of the replication cycle of HIV-1 and several pathogenic human herpes viruses. David’s postdoctoral fellowship focused on exploring the molecular mechanisms underlying breast and ovarian cancer and their impact on the next generation of cancer therapy.

Education and Prior Experience

  • Suffolk University Law School, J.D., Intellectual Property Law Concentration with Distinction
  • Duke University, Ph.D., Molecular Genetics and Microbiology; Certificate, Bioinformatics and Genome Technology
  • Fudan University (Shanghai, China), M.S., Genetics
  • Fudan University (Shanghai, China), B.S., Biochemistry
  • Postdoctoral Fellow at Dana-Farber Cancer Institute and Harvard Medical School
  • Associate and project leader at a research institute affiliated with the World Health Organization (WHO) Collaborating Center in Shanghai, China
  • Author of more than a dozen peer-reviewed research articles published in leading scientific journals, including Cell, Genes and Development, PNAS, PLoS Pathogen, Journal of Virology, RNA andRNA Biology
  • David has presented his research at a number of national and international conferences, including the Annual Meeting for the RNA Society and Keystone Symposia
  • Certificate in computer software engineering from Chinese Ministry of Electronics Industry
  • Fluent in Mandarin and Shanghainese

Admissions, Memberships, and Acknowledgements

  • Admitted to practice law in Massachusetts
  • Registered to practice before the U.S. Patent and Trademark Office
  • Member, Boston Patent Law Association
  • National Institute of Health (NIH) Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship
  • Massachusetts Super Lawyers: Rising Star – Intellectual Property (2019, 2020)